Mechanisms underlying neuronal degeneration in Parkinson's disease: An experimental and theoretical treatise

Movement Disorders

Volumn 4, Issue 1 S, 1989, Pages S15-S25

  Langston, J William ^a  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMELANIN;

AGE; AGED; HUMAN; LEWY BODY; NERVE CELL DEGENERATION; PARKINSON DISEASE; REVIEW;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMAL; BRAIN; CELL SURVIVAL; FREE RADICALS; HUMAN; INCLUSION BODIES; MELANINS; NERVE DEGENERATION; PARKINSON DISEASE; PYRIDINES; RECEPTORS, DOPAMINE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024498507     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.870040504     Document Type: Article

References (42)

1. Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease
2. Etiology
3. An approach to free radicals
4. Influence of age and time interval between death and autopsy on dopamine and 3‐methyoxytryramine levels in human basal ganglia
5. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain
6. Aging and extrapyramidal function
7. The effects of aging on the pigmented nerve cells of the human locus caeruleus and substantia nigra
8. Lipoprotein pigments‐Their relationship to aging in the human nervous system. II. The melanin content of pigmented nerve cells
9. On the origin and siginficance of neuromelanin
10. Possible role of neuromelanin in the pathogenesis of Parkinson's disease
11. Neuromelanin and Parkinson's disease
12. The etiology of Parkinson's disease: new directions for research
13. Monoamine oxidase, hydrogen peroxide, and Parkinson's disease
14. Brain peroxidase and catalase in Parkinson's disease
15. Experimental therapeutics directed at the pathogenesis of PD
16. Neurotoxins, parkinsonism and Parkinson's disease
17. Nigropallidal encephalomalacia in horses caused by ingestion of weeds of the genus centaurea
18. The pharmacology of 6‐hydroxydopamine
19. Mechanisms of neurotoxicity of MPTP
20. MPTP: current concepts and controversies
21. Chronic parkinsonism in humans due to a product of meperidine‐analog synthesis
22. Melanin affinity of 1‐methy1‐4‐phenyl‐1,2,5,6‐tetrahydropyridine, an inducer of chronic parkinsonism in humans
23. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin
24. Evidence for neuromelanin involvement in MPTP‐induced neurotoxicity
25. Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
26. Sited of the neurotoxic action of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus
27. Aging and MPTP‐induced degeneration of dopaminergic neurons in the substantia nigra
28. Inhibition of NADH‐linked oxidation in brain mitochondria by 1‐methy1‐4‐phenylpyridine, a metabolite of the neurotoxin, 1‐methyll‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
29. Energy‐dependent uptake of n‐methyl‐4‐phenylpyridinium, the neurotoxic metabolite of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine, by mitochondria
30. The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence
31. Pathology of Parkinson's disease
32. An electron microscopic study of MPTP‐induced inclusion bodies in an old monkey
33. Parkinson's disease in 65 pairs of twins and in a set of quadruplets
34. Finnish Parkinson's disease twin study: preliminary results
35. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
36. Pargyline prevents MPTP‐induced parkinsonism in primates
37. Intraneuronal generation of a pyridinium metabolite may cause drug‐induced parkinsonism
38. Inhibition of dihydropteridine reductase by novel 1‐methy1‐phenyl‐1,2,3,6‐tetrahydropyridine: analogs
39. Parkinsonism‐inducing neurotoxin, n‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine: uptake of the metabolite n‐methyl‐4‐phenylpyridine by dopamine neurons explains selective toxicity
40. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes
41. Meperidine analog exposure in California narcotics abusers: initial epidemiologic findings
42. Guam amyotrophic lateral sclerosis‐parkinsonism‐dementia linked to a plant excitant neurotoxin